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Modulation of G protein-coupled receptor (GPCR) signaling by local changes in intracellular
calcium concentration is an established function of Calmodulin (CaM) which is known
to interact with many GPCRs. Less is known about the functional role of the closely
related neuronal EF-hand Ca2+-sensor proteins that frequently associate with CaM targets
with different functional outcome. In the present study we aimed to investigate if a
target of CaM—the A2A adenosine receptor is able to associate with two other neuronal
calcium binding proteins (nCaBPs), namely NCS-1 and caldendrin. Using bioluminescence
resonance energy transfer (BRET) and co-immunoprecipitation experiments we show the
existence of A2A—NCS-1 complexes in living cells whereas caldendrin did not associate
with A2A receptors under the conditions tested. Interestingly, NCS-1 binding modulated
downstream A2A receptor intracellular signaling in a Ca2+-dependent manner. Taken
together this study provides further evidence that neuronal Ca2+-sensor proteins play an
important role in modulation of GPCR signaling.
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INTRODUCTION
Adenosine receptors belong to the GPCR family and have been
classified on the basis of their molecular, biochemical, and phar-
macological properties in four subtypes that are broadly dis-
tributed among different tissues including brain. The adenosine
A2A receptor is a Gs coupled receptor (Kull et al., 2000; Vu, 2005)
that modulates cAMP production mediated by adenylyl cyclase
activation upon ligand binding. A2A receptors are particularly
abundant in the basal ganglia and exhibit a somato-dendritic
localization in GABAergic enkephalinergic neurons of the stria-
tum (Schiffmann et al., 2007). However, they can also be found
in several other brain regions including the olfactory bulb and
hippocampus (Sebastião and Ribeiro, 2009). The current under-
standing of the role of A2A receptors in the brain emphasizes
their ability to interact with GPCRs of other neuromodulatory
or neurotransmitter systems, and to provide a fine tuning of neu-
ronal activity (Sebastião and Ribeiro, 2009). A2A receptors mostly
exist as either homodimers or heteromers (Canals et al., 2004;
Sebastião and Ribeiro, 2009). A2A receptor activation facilitates
opioid and CB1 receptor signaling in the striatum (Carriba et al.,
2007; Sebastião and Ribeiro, 2009) and heterodimerization with
the metabotropic glutamate receptor mGluR5 has a synergistic
effect at the level of adenylate cyclase and MAPK activation upon
A2A andmGluR5 receptor co-stimulation (Ferré et al., 2002; Nishi
et al., 2005). The most studied receptor heteromer, however, is the
heteromer of adenosine A2A and dopamine D2 receptor, where
A2A receptors counteract D2 receptor activation (Ferré et al.,
2008; Navarro et al., 2009).
We have previously reported the Ca2+-mediated modulation
of the quaternary structure and function of A2A-D2 receptor
heteromers (Navarro et al., 2009). Calmodulin (CaM) trans-
duces a local change in Ca2+ concentrations to the receptor
heteromer function via direct binding to the carboxy terminus
of the A2A receptor in a A2A-D2 receptor heteromer, modulating
thereby MAPK signaling upon agonist stimulation in a Ca2+-
dependent manner (Navarro et al., 2009). The fine-tuning of
other GPCRs via Ca2+/CaM interaction has been studied already
in some detail (for review see Ferré et al., 2010; Mikhaylova
et al., 2011). Interestingly, the third intracellular loop of many
GPCRs is not only participating in binding of G proteins but
also represents a motif that is predicted to bind CaM. Indeed
CaM can interact in a Ca2+-sensitive manner with dopamine
D2, μ opioid, muscarinergic, and other receptors (Ritter and
Hall, 2009; Ferré et al., 2010). The functional consequences of
the CaM interaction with GPCRs frequently include an atten-
uation of G protein coupling (Nickols et al., 2004; Ritter and
Hall, 2009). Interaction of CaM with the carboxy-terminus has
been demonstrated not only for the adenosine A2A receptor but
for metabotropic glutamate receptors (mGluR5 and mGluR7) as
well (Minakami et al., 1997; Nakajima et al., 1999; Ferré et al.,
2010). However, interaction and modulation of GPCRs signaling
is not an exclusive feature of CaM. Other calcium binding pro-
teins from the CaM superfamily have been shown to interact with
GPCRs directly or can attenuate receptor desensitization via asso-
ciation with the particular G protein-coupled receptor kinases
(GRKs/Kabbani et al., 2002; Komolov et al., 2009). One of the
Frontiers in Molecular Neuroscience www.frontiersin.org April 2012 | Volume 5 | Article 53 | 1
MOLECULAR NEUROSCIENCE
Navarro et al. NCS-1 interacts with adenosine A2A receptors
classical examples is the interaction between the dopamine D2
receptor and NCS-1 where binding of NCS-1 to the cytoplasmic
tail of the D2 receptor inhibits its phosphorylation and subse-
quent internalization after ligand binding (Kabbani et al., 2002).
Therefore, it is conceivable that other calcium binding proteins
from the CaM superfamily could also specifically interact with
certain GPCRs. Evolutionary and historically the neuronal mem-
bers of the CaM superfamily are divided into two large groups
named neuronal calcium sensor proteins (NCS) and neuronal
Calcium Binding proteins (nCaBPs/Mikhaylova et al., 2011).
Both groups resemble the structure of their common ances-
tor (CaM) with four EF-hand Ca2+-binding motifs. However,
not all EF-hands are able to bind Ca2+ ions although they still
might be involved in protein-protein interactions. In the current
study we aimed to investigate whether one of the most abun-
dant and widely distributed members of the NCS group—NCS-1
(Burgoyne, 2007; Mikhaylova et al., 2011) and the founding
member of the nCaBP group—caldendrin (Seidenbecher et al.,
1998) are able to associate with the adenosine A2A receptor. All
three proteins have overlap in their expression profiles and can
be found in the same brain regions and the same type of neu-
rons (Sebastião and Ribeiro, 1996; Martone et al., 1999; Laube
et al., 2002; Bernstein et al., 2003; Rosin et al., 2003). To address
this issue we implemented bioluminescence resonance energy
transfer (BRET) and co-immunoprecipitation approaches and
checked the functional role of the interaction by A2A recep-
tor agonist induced MAPK and AKT signaling in co-transfected
HEK293 cells.
MATERIALS AND METHODS
cDNA CONSTRUCTS AND ANTIBODIES
cDNA constructs encoding human adenosine A2A receptor (A2A
in pEYFP-N1, A2A in pRluc-N1, and A2A in pGFP-2-N1 vectors)
or human dopamine D2 receptor and CaM in pEYFP-N1 vec-
tor, were previously described (Navarro et al., 2009). NCS-1 in
pEYFP-N1 vector was published previously (Zhao et al., 2001).
NCS-1 in pTagRFP-N or pEGFP-N1 vectors was subcloned from
the pNCS-1-YFP-N1 plasmid using XhoI and BamHI restric-
tion sites. Caldendrin was subcloned from a caldendrin-EGFP-
N1 plasmid (Dieterich et al., 2008) into a pEYFP-N1 vector
using EcoRI and BamHI restriction sites. The identity of the
newly cloned construct was confirmed by sequencing analysis.
pEGFP-N1 (Clontech), pTagRFP-N (Evrogen, Moscow, Russia),
and pcDNA3.1 (Invitrogen, Darmstadt, Germany) were used as
a corresponding negative controls for co-immunoprecipitation
experiments and in surface biotinylation studies.
The following primary antibodies were used: Anti-NCS-1
rabbit (Santa Cruz Biotechnology, Heidelberg, Germany), anti-
GFP mouse (MMS-118R, HiSS Diagnostics, Freiburg, Germany),
anti-Renilla Luciferase mouse (Millipore, Schwalbach, Germany),
anti-phospho-ERK1/2 mouse (Sigma-Aldrich, Madrid, Spain),
anti-ERK1/2 rabbit (Sigma-Aldrich, Madrid, Spain), and anti-
phospho-AKT rabbit (SAB Signalway antibody, Madrid, Spain).
The secondary antibodies were: goat anti-mouse immunoglob-
ulins HRP conjugated (P0447, Dako, Hamburg, Germany), goat
anti-rabbit IgGHRP conjugated (#7074, Cell Signaling, Frankfurt
am Main, Germany), peroxidase-AffiniPure goat anti-mouse
IgG, light chain* specific antibody (Jackson ImmunoResearch)
and Alexa Fluor 568 goat anti-rabbit IgG (A11031, A11036,
Invitrogen, Darmstadt, Germany).
CELL CULTURE AND TRANSIENT TRANSFECTION
HEK293, HEK-293T cells, and COS-7 cells were grown in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 2mM L-glutamine, 100 U/ml penicillin/streptomycin, and
5% (v/v) heat inactivated Fetal Bovine Serum (FBS) (Invitrogen,
Paisley, Scotland, UK). For immunocytochemistry experiments
HEK-293 and COS-7 cells were plated on 18mm coverslips,
grown for 24 h and then transfected with Lipofectamine 2000
(Invitrogen, Karlsruhe, Germany) according to the manufac-
turer’s protocol. Twenty-four hours after transfection the cells
were fixed with 4% paraformaldehyde (PFA) and processed
for immunostaining as described below. For surface biotiny-
lation experiments HEK293T cells were grown in 75 cm2 cul-
ture flasks and transfected with Polyfect (Qiagen) according to
the manufacturer’s protocol. HEK-293T cells for BRET experi-
ments were transfected with the plasmids encoding CaM, NCS-1,
caldendrin, and adenosine A2A receptor fusion proteins by PEI
(PolyEthylenImine, Sigma, Steinheim, Germany) as previously
described (Carriba et al., 2008).
IMMUNOCYTOCHEMISTRY, LASER SCANNING MICROSCOPY,
AND IMAGE ANALYSIS
Coverslips with transfected HEK-293 and COS-7 were fixed
with 4% PFA for 10min at 37◦C, extensively washed with
PBS and immunostained for endogenous NCS-1 as described
before (Mikhaylova et al., 2009) with anti-NCS-1 rabbit anti-
body in a dilution of 1:300. COS-7 cells transfected with A2A-Rluc
construct were stained with anti-Renilla Luciferase mouse anti-
body in dilution 1:500. F-actin was stained with Alexa Fluor
568 phalloidin (Molecular probes, Life Technologies, Darmstadt,
Germany) diluted in 1:1000 in PBS and incubated for 10min
at room temperature. Fluorescence images were obtained on a
TCS SP5 II confocal laser scanning microscope (Leica, Germany)
using a 63× oil objective and zoom factors in the range of
1–4×. A 405 laser line was used for visualizing DAPI staining,
488 for GFP/YFP, 568 for the Alexa 568, and TagRFP. Images were
acquired as z-stacks with 0.3μm z-step. Maximum projections of
z-stack were created in the ImageJ program (ImageJ, NIH).
BRET ASSAYS
HEK-293T cells were grown in six-well plates till about 60%
confluence and then were transiently co-transfected with a con-
stant amount of cDNA encoding for Rluc fusion protein and
with increasing amounts of cDNA, corresponding to the pro-
tein fused to YFP. Two hours before quantifying fluorescence
intensity, the supplemented medium (DMEM) was replaced by
HBSS in the presence (1.26mM) or in the absence of Ca2+.
Cells supplemented with Ca2+ were treated with 1μm of iono-
mycin 10min prior to the fluorescence measurements. To quan-
tify protein-YFP expression, cells (20μg protein) were distributed
in 96-well microplates (black plates with a transparent bot-
tom), and fluorescence was read in a Mithras LB 940 using an
excitation filter at 400 nm. Protein-fluorescence expression was
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determined as fluorescence of the sample minus the fluorescence
of cells expressing the BRET donor alone. For BRET measure-
ments, cell suspensions (20μg protein) were distributed in 96-
well microplates (Corning 3600, white plates; Sigma) and 5μM
coelenterazine H (Molecular Probes, Eugene, OR) was added.
After 1min, the readings were collected using a Mithras LB
940 that allows the integration of the signals detected in the
short-wavelength filter at 485 nm (440–500 nm) and the long-
wavelength filter at 530 nm (510–590 nm). To quantify protein-
Rluc luminescence readings were also collected after 10min of
adding coelenterazine H. The net BRET is defined as [(long-
wavelength emission)/(short-wavelength emission)]-Cf where Cf
corresponds to [(long-wavelength emission)/(short-wavelength
emission)] for the donor construct expressed alone in the same
experiment. BRET is expressed as mili BRET units (mBU) deter-
mined as net BRET × 1000. A hyperbolic saturation curve
showing an increase in BRET signal as a function of the accep-
tor fusion protein expression (acceptor protein expression relative
to the donor protein expression, YFP/Rluc) is indicative of a spe-
cific interaction between the receptor-Rluc and Ca2+ sensor-YFP
fusion constructs (Ayoub and Pfleger, 2010). BRET curves were
fitted by using a non-linear regression equation, assuming a sin-
gle phase with GraphPad Prism software (San Diego, CA, USA) to
obtain the BRETmax and BRET50 values. The BRET50 parameter
represents the acceptor/donor ratio giving 50% of the BRETmax
and was used to estimate the relative affinity of the interaction.
BRET data are expressed as means ± S.E.M. of 4–6 different
experiments grouped as a function of the amount of BRET accep-
tor. Statistical differences in BRET parameters were analyzed
with bifactorial ANOVA followed by post-hoc Bonferroni’s tests
(p = 0.05).
CO-IMMUNOPRECIPITATION ASSAY (CO-IP) AND IMMUNOBLOTTING
Heterologous Co-IP was performed with extracts from HEK293T
cells transiently expressing A2A-YFP, D2-YFP, GFP, and NCS-1-
tagRFP. Endogenous NCS-1 was co-immunoprecipitated from
HEK293T cells transfected only with A2A -YFP or GFP plas-
mids. YFP-tagged receptors and GFP control were immuno-
precipitated for 12 h at 4◦C with anti-GFP mouse antibody
coupled to magnetic beads. Purification of antibody bound com-
plexes was done using the μMACS™ GFP Isolation Kit (Miltenyi
Biotec GmbH, Germany) according to the protocols supplied
by manufactures, except that six washing steps were introduced
to remove the unspecific binding to the beads. Another set of
experiments was performed for A2A-YFP and GFP with overex-
pressed NCS-1-TagRFP. Extraction of proteins from HEK293T
cells was done as described previously (Hradsky et al., 2011).
NCS-1 was immunoprecipitated with anti-NCS-1 rabbit anti-
body coupled to Protein G sepharose (GE Healthcare) or cor-
responding rabbit IgG controls overnight at 4◦C. In both cases,
high Ca2+ and Ca2+-free conditions were achieved by addition
of 0.5mM of Ca2+ and 1mM of Mg2+ or 2mM EGTA and
1mM Mg2+, respectively, to the cell extracts during immuno-
precipitation as well as into the washing buffers. Beads with
precipitated protein complexes were washed three times with cor-
responding extraction buffers and eluted with 2× SDS sample
buffer. Eluted samples were checked on SDS-PAGE/WB using
anti-NCS-1 and anti-GFP antibody. To measure the effect of
Ca2+ on the efficiency of co-immunoprecipitation, the total
amount of A2A receptor co-purified at different conditions was
quantified using the “Gel Analyzer” plug-in provided in the
ImageJ software (NIH, USA). The maximal binding observed
with anti-NCS-1 antibody in the presence of Ca2+ was taken
as 100% for each experiment individually and % deviations
from this condition were measured for the other groups.
Confidence interval was calculated and data were represented
as averages of 4–5 independent experiments ± standard error
mean (S.E.M).
SURFACE BIOTINYLATION ASSAY
HEK293T cells overexpressing A2A -YFP alone or together with
NCS-1-TagRFP and GFP control co-transfected with NCS-1-
TagRFP were grown for 48 h in supplemented DMEM. Then
growthmedium was removed, cells were washed twice with HBSS
and serum-free DMEM was added for another 2 h. Cells were
labeled with Sulfo-NHS-SS-Biotin (Pierce) for 15min at 4◦C
according to the manufacturers manual. Unbound biotin was
sequestered and cells were harvested by scrapping, proteins were
extracted with 1× TBS containing 1% Triton-X-100 over 1 h at
4◦C. Equal amounts of extract were bound to Streptavidin beads
(Life Technologies) and biotinylated proteins were eluted with
2× SDS and subjected to SDS-PAGE. A2A -YFP protein bands
were detected with anti-GFP mouse antibody. NCS-1-TagRFP
was visualized with anti-NCS-1 rabbit antibody on the same
membrane. The efficiency of surface biotinylation for A2A–YFP
in the presence or absence of NCS-1-TagRFP (n = 4) was quanti-
fied by measuring the optical densities of GFP signal as described
above. Obtained values were compared between groups with and
without overexpressed NCS-1 (the later one is taken as 100%).
Statistical comparisonwas done with bifactorial ANOVA followed
by post-hoc Bonferroni’s tests.
MAPK AND AKT PHOSPHORYLATION ASSAYS
A detailed protocol for activation of adenosine A2A receptors in
HEK293T cells by addition of the A2A receptor agonist CGS21680
(100 nM) has been described previously (Navarro et al., 2009).
Briefly, HEK293T cells expressing A2A and NCS-1 or the corre-
sponding controls were grown in 25 cm2 flasks to 50% confluence
and cultured in serum-free medium overnight before the exper-
iment. Two hours before the experiment, the cells medium was
changed to HBSS buffer containing 1.26mM Ca2+ and cells
were treated or not with 1μM ionomycin for 5min before the
addition of CGS21680. After cell lysis and estimation of pro-
tein concentration equal amounts of each sample (10μg) were
subjected to SDS-PAGE. To determine the level of ERK1/2 and
pAKT phosphorylation, the membranes were then probed with
a mouse anti-phospho-ERK1/2 antibody or phospho-AKT anti-
body. Total-ERK1/2 antibody was used as a loading control. The
levels of phosphorylated ERK1/2 and phosphorylated AKT were
normalized for differences in loading using the total ERK1/2 pro-
tein bands. Quantitative analysis of detected bandswas performed
by Odyssey V3.0 software. Statistical comparison was done
with bifactorial ANOVA followed by post-hoc Bonferroni’s tests
(∗p = 0.05).
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RESULTS
MOLECULAR INTERACTIONS BETWEEN ADENOSINE A2A
RECEPTOR AND CALCIUM SENSOR PROTEINS IN LIVING CELLS
The BRET technique can be successfully used as a method to test
a protein—protein interaction in living cells (De and Gambhir,
2005; Carriba et al., 2008). Particularly, previously reported direct
binding between the carboxy terminus of the A2A receptor and
CaM (Woods et al., 2008) was verified and extensively charac-
terized using BRET (Navarro et al., 2009). This method is based
on the fact that a luminescent donor (Rluc) oxidates the sub-
strate coelenterazine H emitting bioluminescence that can be
transferred to a fluorescent acceptor (YFP) when the distance
between the donor and the acceptor is about 4.4 nm, (Dacres
et al., 2010)—a typical distance between proteins interacting in
a macro complex. The advantage of the BRET technique over
classical techniques like co-immunoprecipitation is that it is per-
formed in living cells and the protein concentrations of each
protein can be carefully controlled with the interaction moni-
tored over a range of protein concentrations and ratios. We have
chosen BRET to test if the A2A receptor is capable of form-
ing a complex with other members of the CaM superfamily,
namely NCS-1 and caldendrin. We compared the BRET effi-
ciency between HEK293T cells co-expressing A2A fused to Renilla
luciferase (Rluc) and CaM, NCS-1 or caldendrin fused to YFP
(Figures 1A–C). In agreement with our previous findings, the
saturation curve obtained upon increasing CaM-YFP expression,
indicated a specific interaction between CaM and A2A (BRETmax
60 ± 7 mBU and BRET50 41 ± 6). BRET occurred already at
resting conditions but BRETmax was increased (p = 0.05) after
10min of stimulation with 1μM of ionomycin (BRETmax 78 ±
7 and BRET50 48 ± 8/Figure 1A). Interestingly, a clear and sat-
urable BRET signal was also observed when increasing amounts
of NCS-1-YFP were co-expressed with a constant amount of A2A-
Rluc (BRETmax 43 ± 4 mBU and BRET50 11 ± 5, Figure 1B)
again demonstrating a specific interaction. Elevation of intra-
cellular Ca2+ concentration by preincubation of HEK293T cells
with ionomycin (1μM) for 10min, increased (p = 0.05) both
BRETmax (57 ± 6 mBU) and BRET50 (33± 9/Figure 1B). These
results can be interpreted in two ways, neither of which is exclu-
sive of the other. In one, Ca2+ led to conformational changes in
the A2A-NCS-1 complex that reduces the distance between Rluc
and YFP fused to the C-terminal domain of the two interacting
fusion proteins. In the other, Ca2+ increases complex formation
by increasing the affinity between the two proteins.
Next we investigated if A2A and caldendrin can form het-
eromers. A non-specific (linear) and low BRET signal was
obtained in this case, a result consistent with two proteins not
interacting (Figure 1C). An increase in intracellular Ca2+ lev-
els had no effect on BRET efficiency either. Taken together these
results suggest that caldendrin might not be an interaction part-
ner of the A2A receptor and that not all EF-hand proteins produce
a BRET signal indicative of an interaction.
To get more insight in this, we performed co-immuno-
precipitation experiments with transfected HEK293T cells.
Interestingly, we found that NCS-1 is expressed endogenously in
this cell line (Figures 2A,B). Immunostaining with anti-NCS-1
antibody showed an extranuclear punctate pattern as expected
for a N-terminal myristoylated protein that exhibits membrane
FIGURE 1 | Adenosine A2A receptors interact with calmodulin and
NCS-1 but not with caldendrin. BRET measurements were performed in
HEK-293T cells co-transfected with 0.2μg cDNA corresponding to the donor
A2A-Rluc and increasing amounts of the cDNA (0.1–2μg) corresponding to
CaM-YFP (A), NCS-1-YFP (B) or caldendrin-YFP (C). In A and B a clear BRET
saturation curves were seen. Both interactions occur at basal Ca2+ levels
(black curve) but can be facilitated in the presence of Ca2+/ionomycin (red
curve). No positive BRET interaction was seen for A2A-Rluc and
caldendrin-YFP at either Ca2+ concentrations (C). Both fluorescence
and luminescence of each sample were measured before every
experiment to confirm similar donor expression (approximately 100,000
bioluminescence units) while monitoring the increase in acceptor
expression (1000–35,000 fluorescence units). The relative amount of BRET is
given as a function of 100× the ratio between the fluorescence of the
acceptor (YFP) and the luciferase activity of the donor (Rluc). Average of
5–6 independent experiments measured in triplicates are plotted as mean
value ± S.E.M. At the top images a schematic representation of BRET is
given.
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FIGURE 2 | Adenosine A2A receptors form a complex with endogenous
and the overexpressed NCS-1 in co-immunoprecipitation experiments.
HEK293 cells express endogenous NCS-1 (A) that shows partial
co-localization with overexpressed adenosine A2A receptor at the plasma
membrane of transfected cells (low panel, white arrows indicate the
co-localizing spots). (B) HEK293T cell transfected with NCS-1-TagRFP or
Tag-RFP probed with anti-NCS-1 rabbit antibody. NCS-1-TagRFP band can bee
seen in the range of 45 kDa. Note a weak 18 kDa band of endogenous NCS-1
present in both samples. Additional band about 25 kDa in the first lane could
be a degradation product of NCS-1-TagRFP. (C) Overexpressed A2A-YFP and
NCS-1-TagRFP can be co-immunoprecipitated from HEK293T cell extract.
Dopamine D2 receptor with YFP-tag is included as a positive control.
YFP-fused receptors or GFP control were detected with anti-GFP mouse
antibody, detection of NCS-1-TagRFP was done with anti-NCS-1 rabbit
antibody. (D) Endogenous NCS-1 is co-immunoprecipitated with A2A-YFP
from HEK293T cell extract. (E) Immunoprecipitation (IP) is performed with
anti-NCS-1 rabbit antibody. Anti-NCS-1 antibody show positive
immunoprecipitation of the antigene (low panel). Note, that there is
endogenous NCS-1 expressed in HEK293 cells but at much lower levels then
overexpressed NCS-1. Mostly a homomeric form of A2A-YFP is detected with
anti-GFP mouse antibody (upper panel). (F) The binding of A2A receptor to
NCS-1 is enhanced in the presence of Ca2+. Quantification of
immunoprecipitated A2A-YFP. Data represented as average of 4–5
independent experiments ± SEM.
localization. The co-localization between endogenous NCS-1 and
overexpressed A2A-YFP was mostly restricted to the cell periph-
ery (Figure 2A). We then performed co-immunoprecipitation
experiments with HEK293T cells co-transfected with A2A-YFP
and NCS-1-TagRFP or the corresponding control contructs
(Figure 2C). Dopamine D2 receptor (D2-YFP) was included as
a positive control since its interaction with NCS-1 is well estab-
lished (Kabbani et al., 2002; Lian et al., 2011). The mouse
anti-GFP antibody led to immunoprecipitation of receptor-
YFP in complex with overexpressed (Figure 2C) or endogenous
(Figure 2D) NCS-1. In the case of overexpression, the binding of
NCS-1 to D2 and A2A receptors already occurred in the presence
of EGTA (Figure 2C). Immunoprecipitation of overexpressed and
endogenous NCS-1 with rabbit anti-NCS-1 bound to Protein G
sepharose have shown that A2A-YFP was efficiently co-purified
with NCS-1-TagRFP (Figure 2E). The corresponding controls
with unspecific rabbit IgG showed again some unspecific bind-
ing of N-myristoylated NCS-1 to the beads but it was significantly
lower as compared to immunoprecipitations done with the anti-
NCS-1 antibody (Figures 2E,F). Interestingly, analogous to the
BRET experiments the presence Ca2+ had a positive effect on
the interaction (Figures 2D,E and F) and mostly a homomeric
A2A-YFP receptor formed a complex with NCS-1 (Figure 2E).
OVEREXPRESSION OF NCS-1 HAS NO IMPACT ON SURFACE
EXPRESSION OF THE A2A RECEPTOR IN NON-STIMULATED CELLS
NCS-1 is involved in regulation of vesicular trafficking from
the trans-Golgi network (TGN) to the plasma membrane and
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associates with the Golgi membranes via its N-terminal myristoyl
tail where it regulates activity of phosphatidylinositol 4-kinase
IIIβ (PI-4KIIIβ), thus providing a Ca2+-dependent control for
the regulated local synthesis of phosphatidylinositol 4-phosphate
(PI(4)P) and for the exit of vesicles from TGN (Zhao et al.,
2001; Haynes et al., 2005; Mikhaylova et al., 2009). At the plasma
membrane NCS-1 is involved in transduction of Ca2+ signal-
ing and regulating the activity of different kinases and surface
receptors (for review see Mikhaylova et al., 2011). A2A receptor
traverses the secretory trafficking pathway from the ER to the
Golgi complex on the way to the plasma membrane. Therefore,
we next asked how the presence of NCS-1 would affect the expres-
sion of A2A receptor at the plasma membrane and where in
the cell the complex of A2A receptor and NCS-1 might occur.
To address the first question, we performed a quantitative sur-
face biotinylation assay to compare the surface expression of A2A
receptor with and without co-transfection of NCS-1. Two major
bands corresponding to the monomer and the dimer of A2A
receptor were biotinylated and purified with streptavidin beads
(Figure 3A). Additional bands appearing in streptavidin-bound
fraction but not in whole-cell extract might represent a differ-
entially modified (for example glycosilated, phosphorylated, etc.)
plasma membrane receptor fraction. Although there we observed
a slight increase in immunoreactivity of biotinylated A2A when
co-expressed with NCS-1, we have not found any significant
effect on surface receptor expression in non-stimulated HEK293T
cells (Figure 3B). Next, for the co-localization study we have
chosen COS-7 cells because they are significantly larger than
HEK293T cells. After 24 h of overexpression, significant amounts
of A2A-YFP fluorescence was still associated with the ER and
the Golgi membranes. Considerable overlap of A2A -YFP and
NCS-1-TagRFP fluorescence, however, was mostly seen close to
the plasma membrane compartment (Figure 3C). Therefore, in
another set of experiments we included phalloidin-568 staining to
visualize a dense cortical actin cytoskeleton along the cell mem-
branes. Additionally, since the excitation/emission spectrum of
TagRFP is largely overlapping with Alexa Fluor 568, we replaced
the fusion constructs by NCS-1-YFP and A2A-Rluc (Figure 3D).
Again we could see a co-localization of A2A and NCS-1 fluores-
cence overlapping with F-actin at the edges of the cell membrane
FIGURE 3 | NCS-1 does not interfere with the trafficking and surface
expression of adenosine A2A receptors in the basal conditions
(no agonist stimulation). (A) HEK293T cells overexpressing A2A-YFP alone
or together with NCS-1-TagRFP and GFP control co-transfected with
NCS-1-TagRFP were labeled with Sulfo-NHS-SS-Biotin for 15min at 4◦C and
biotinylated proteins were purified with Streptavidin beads. Detection was
done with anti-GFP and anti-NCS-1 antibody. Note the SDS-resistant dimer of
A2A-YFP. NCS-1-TagRFP is also co-purified with surface biotinylated proteins
suggesting that there might be another binding partner of NCS-1
endogenously expressing in HEK293T cells. (B) Although there are slight
differences in amount of surface labeled A2A-YFP between TagRFP and
NCS-1-TagRFP expressing cells, no clear effect of NCS-1 overexpression can
be seen. (C) Confocal image of a COS-7 cell co-expressing with A2A-YFP and
NCS-1-TagRFP for 24 h shows co-localization of both proteins at the cell
periphery (D) A2A-Rluc co-localizes
with NCS-1-YFP and cortical F-actin along the plasma membrane of
transfected COS-7 cells. Note the intracellular vesicular structures showing
overlapping fluorescence of A2A and NCS-1.
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as well as in small clusters in the cytosol (Figure 3D). These clus-
ters could represent post-Golgi transport carriers, endosomes or
some other vesicular compartments.
BINDING OF NCS-1 TO THE A2A RECEPTOR DIMER HAS A
DIFFERENTIAL EFFECT ON AGONIST-INDUCED INTRACELLULAR
SIGNALING
Homodimers of adenosine A2A receptor are the predominant
form of the receptor at the cell membrane (Canals et al., 2004).
Moreover, based on the co-immunprecipitation data, where
mostly the homomeric form of A2A was co-purified with NCS-1,
we questioned if NCS-1 could interact with the A2A homodimer.
We performed BRET saturation curves in HEK293T cells express-
ing an A2A- Rluc and increasing amounts of A2A-YFP in the pres-
ence or absence of NCS-1 (Figure 4A). The presence of NCS-1
modified the BRETmax (p = 0.01) and BRET50 (p = 0.05) corre-
sponding to the formation of a A2A homodimer (BRETmax 196 ±
10 mBU and BRET50 63 ± 7 in the absence of NCS-1; BRETmax
131 ± 9mBU and BRET50 90 ± 10 in the presence of NCS-1).
This result demonstrates that NCS-1 interacts with A2A receptor
homodimers and induces changes in their quaternary structure
in a manner that suggests a greater distance between donor and
acceptor, a change in orientation, and/or a diminished number of
heteromers. Another possibility that we cannot exclude would be
FIGURE 4 | NCS-1 associates with a A2A–A2A homodimer and modulates
the adenosine A2A receptor signaling in a Ca2+ dependent manner.
(A) BRET saturation curves were obtained from HEK-293T cells
co-transfected with 0.2μg cDNA corresponding to A2A-Rluc fusion protein
and increasing amounts of cDNA (0.05–1μg) corresponding to A2A-YFP
fusion protein without (black and red curves) or with 0.5μg of the cDNA
corresponding to NCS-1 (green and blue curves). Measurements were done
either at basal conditions (black and green curves) or after treatment of cells
with 1μM of ionomycin for 10min (red and blue curves). Ca2+ has no
effect on A2A receptor homodimerization itself (red curve compared to the
black one) but modifies A2A-A2A-NCS-1 heteromeric complex structure
(blue curve compared to the green one). Both fluorescence and
luminescence of each sample were measured before every experiment to
confirm similar donor expression (approximately 100,000 bioluminescence
units) while monitoring the increase in acceptor expression (1000–27,000
fluorescence units). The relative amount of BRET is given as a function of
100× the ratio between the fluorescence of the acceptor (YFP) and the
luciferase activity of the donor (Rluc). Average of 5–6 independent
experiments measured in triplicates are plotted as mean value ± S.E.M. A
schematic representation of BRET is given at the top. In (B) and (C)
HEK-293T cells transfected with 0.5μg cDNA corresponding to adenosine
A2A receptor alone or with cDNA corresponding to caldendrin-YFP (0.8μg) or
NCS-1-YFP (0.6μg) were stimulated with 100nM of CGS 2168 at the basal
condition, in the presence of 1.26mM of Ca2+ in HBSS buffer or in the
presence of both 1.26mM of Ca2+ and 1μM of Ca2+ ionophore ionomycin.
Equal amount of protein were analyzed by SDS-PAGE using phospho-ERK1/2
(B) or phospho-AKT (C) and total-ERK1/2 antibodies. Quantification of
eight independent experiments indicates stimulatory effect on NCS-1 on
MAPK signaling (B) or pAKT levels (C) at the basal Ca2+ conditions.
∗p = 0.05.
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a change in the density of adenosine A2A receptors at the plasma
membrane upon overexpression of NCS-1. However, we have not
found significant increases in the amount of A2A receptor associ-
ated with the plasma membrane using surface biotinylation assay
(Figure 3A). BRET experiments were always carried out at con-
stant amounts of receptors between compared groups. Since we
performed our study in intact HEK293T cells, a small change in
plasma membrane density of A2A receptors would presumably
be compensated for by a change in density in other intracellu-
lar membranes. Thus, the changes measured in the BRET assay
are most likely due to differences in receptor-receptor interac-
tion. An elevation in Ca2+ levels by treating cells with ionomycin
(1μM) did not modify A2A–A2A homomerization but modi-
fied the BRET50 (p = 0.05) in the presence of NCS-1 (BRETmax
148 ± 10mBU and BRET50 48 ± 7), indicating a change in the
receptor association between NCS-1 and the A2A heteromer in
the presence of Ca2+ (Figure 4A).
The adenosine A2A receptor is a Gs coupled receptor that
regulates cAMP production. The activation of the A2A receptor
regulates a number of protein and lipid kinases, including MAPK
1-3 (ERK1/2) phosphorylation and activity (Wyatt et al., 2002;
Navarro et al., 2009) and V-akt murine thymoma viral onco-
gene homolog 1 (AKT, also called PKB/Mori et al., 2004). To
test the effect of NCS-1 overexpression on A2A receptor func-
tion we analyzed MAPK and AKT signaling pathways. 2-[p-(2-
carboxyethyl)phenylethylamino]-50 ethylcarboxamidoadenosine
(CGS 21680) is a selective agonist of A2A type of adenosine recep-
tors. CGS21680-induced ERK1/2 and AKT phosphorylation was
assessed in transiently transfected HEK293T cells at basal con-
ditions or at elevated calcium levels. Agonist stimulation of A2A
in NCS-1-YFP transfected cells induced a significant increase
in ERK1/2 phosphorylation at basal conditions and this effect
was reversed when cells were pre-treated with Ca2+/Ionomycin
(Figure 4B). As a negative control, overexpression of caldendrin-
YFP, that showed no interaction with A2A receptors, had no effect
on ERK1/2 activity at any condition tested, demonstrating further
the specificity of the NCS-1-induced effects (Figure 4B). Finally,
NCS-1 promoted the CGS21680-induced AKT phosphorylation
at resting Ca2+ levels and again this effect was blocked when
intracellular Ca2+ concentrations were increased with ionomycin
(Figure 4C).
DISCUSSION
Adenosine receptors cross talk has been established with other
GPCRs, ionotropic receptors, and receptor kinases to regulate
their function with most of the characterized interactions occur
via the A2A receptor type (Sebastião and Ribeiro, 2009). Most
important, the role of A2A receptors in the brain is related to
their ability to interact with other receptor systems (Sebastião
and Ribeiro, 2009). Indeed, cross talk between the A2A recep-
tor and D2 type dopamine receptor, metabotropic glutamate
receptor mGluR5 or endocanabinoid receptor CB1 in striatum
modulates the signaling induced by these receptors and has
important clinical implications for the treatment of Parkinson
disease, schizophrenia, addiction, and potentially other brain
disorders (Ferré et al., 2002; Carriba et al., 2007; Ferré et al.,
2008).
Another level of complexity to the regulation of GPCRs signal-
ing is added by cross talk between GPCRs system and intracellular
Ca2+ signaling via CaM. Among a number of other GPCRs,
CaM has been shown to bind to the carboxy-terminus adeno-
sine A2A receptors in a A2A-D2 receptor heteromer. Elevation
of intracellular Ca2+ levels then triggers conformational changes
in this complex via CaM providing a selective modulation of
A2A-D2 receptor heteromer-mediated activation of the MAPK
pathway (Navarro et al., 2009). Evolutionary and based on the
history of their discovery, calcium sensors from the CaM super-
family that are particularly abundant in brain are divided into two
larger groups named NCS and nCaBPs (Mikhaylova et al., 2011).
Although CaM is ubiquitously expressed in all eukaryotic cells,
emerging evidence supports a role for NCS and nCaBPs other
than CaM in the regulation of a number of effectors. For example,
there are interactions that are specific for particular calcium sen-
sors (hippocalcin—PSD95; caldendrin—LC3/Seidenbecher et al.,
2004; Dieterich et al., 2008; Jo et al., 2010) and that cannot be
competed by CaM. Moreover, many CaM targets can interact
with more than one NCS or nCaBPs. Voltage-gated Ca2+ chan-
nels (CaV) (P/Q-, N-, and L-type), TRPC1/5 channels, GPCRs,
IP3R, and PI-4KIIIβ are among them (for review see Mikhaylova
et al., 2011). We have chosen two representative candidate pro-
teins from each group of CaM-like calcium sensors. NCS-1 (also
known as frequinin) is one of the first discovered and well-
characterized NCS proteins. NCS-1, like other members of this
family of proteins, has a widespread distribution in the brain and
spinal cord (Martone et al., 1999). In terms of its structural orga-
nization, NCS-1 can associate with intracellular membranes via
a N-terminal myristoyl tail and like CaM it has four EF-hand
motifs where the first EF-hand is cryptic and does not coordinate
Ca2+. Differently from CaM that displays a dumbbell confor-
mation of the two EF-hand domains, NCS-1 exhibits a globular
fold and NCS-1 can bind Ca2+ with higher affinity than CaM
(in the range of 0.5–0.8μM in Mg2+ bound form/Aravind et al.,
2008; Mikhaylova et al., 2009). Ca2+ binding induces confor-
mational changes and the exposure of hydrophobic surfaces for
the interaction with the target protein or membrane. Caldendrin
is the founding member of the nCaBP group of Ca2+ sensors
(Seidenbecher et al., 1998). Most important, based on align-
ments of its carboxy terminal half that resembles the organization
of CaM, caldendrin is the closest homolog of CaM in brain
(Seidenbecher et al., 1998; Mikhaylova et al., 2006, 2011; McCue
et al., 2010).
To test if NCS-1 and caldendrin are able to interact with A2A
receptor in living cells we measured BRET between A2A—Rluc as
the donor and calcium sensor—YFP as the acceptor. We observed
a positive saturable signal only between A2A and NCS-1 but
not caldendrin. This result was surprising, as caldendrin is more
closely related to CaM than NCS-1. Like CaM, binding of NCS-
1 occurred already under basal Ca2+-conditions and was further
facilitated by increased intracellular Ca2+ levels. We were able
to confirm these data by heterologous co-immunoprecipitations
from HEK293T cells transiently expressing A2A or D2 receptors
and NCS-1. These data suggest that NCS-1 is a novel interaction
partner of A2A receptor. Both proteins associate with membranes
and can be found along the secretory trafficking pathway but
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mainly co-localize at the post-Golgi trafficking compartments
including the cell membrane. Although there was a slight increase
in the amount of surface receptor when cells were overexpressing
NCS-1, this might be due to the stimulatory effect of NCS-1 on
the activity of the Golgi localized enzyme PI-4KIIIβ but not likely
due to trafficking of A2A itself. Activation of PI-4KIIIβ leads to the
increase in production of PI(4)P—rate limiting phosphoinositide
in the TGN-to-plasma membrane trafficking (Zhao et al., 2001;
Haynes et al., 2005; Mikhaylova et al., 2009) and would in general
enhance the surface delivery of transmembrane proteins.
Using BRET we have found that NCS-1 is associated with a A2A
homodimer. More than 90% of A2A overexpressed in HEK293T
cells is functional only in dimeric form (Canals et al., 2004) and
this indicates that NCS-1 associates with a functional A2A recep-
tor. Interestingly, in a recent paper of Lian and colleagues (2011)
the NMR structure of Ca2+-bound NCS-1 and the dopamine D2
receptor binding peptide have indicated that monomeric NCS-1
can simultaneously bind two D2 receptors. Similarly, Ca2+ sta-
bilizes a A2A-A2A-NCS-1 heteromeric complex. It is tempting
to speculate, that this might relate to conformational changes
in monomeric NCS-1 which induces conformational changes in
the heteromer which then has differential consequences in terms
of agonist-induced intracellular signaling. At basal conditions,
stimulation with the A2A receptor agonist CGS21680 had a pos-
itive effect on phosphorylation of ERK1/2 and AKT. In contrast,
preincubation of cells with Ca2+/ionomycin reduced the agonist-
induced ERK1/2 phosphorylation. Most important, this effect is
specific for NCS-1 since overexpression of CaM had no effect
on A2A receptor homomer signaling but instead was important
for A2A—D2 induced ERK1/2 phosphorylation (Navarro et al.,
2009). The contribution of endogenous NCS-1 from HEK293
cells is probably very minor since the expression levels are quite
low and we have not seen any change induced by elevated Ca2+ in
the cells overexpressing only A2A receptor alone.
In summary, in this study we provide the first evidence for a
novel interaction between the adenosine A2A receptor and NCS-
1. We demonstrate that Ca2+ modulates both the association and
the intracellular signaling in living cells and that this effect is spe-
cific for NCS-1 in the sense that caldendrin does not bind and that
the association of CaM has different functional consequences.
Understanding the role of NCS-1 in heteromerization of GPCRs
will provide further insights on the function of GPCRs and might
have potential clinical applications.
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